How far may companies go in setting parameters around the removal of directors? The Delaware Chancery Court is slated this month to hear argument in a case involving that issue.
The oral argument, scheduled for Sept. 26, involves a shareholder lawsuit challenging a director-removal bylaw of Pennsylvania-based weight-loss products provider Nutrisystem Inc. The bylaw states that Nutrisystem board members may only be removed if two-thirds of the stockholders vote in favor of the removal.
According to the shareholder’s complaint, the clause improperly entrenches the company’s directors, in violation of Delaware General Corporation Law Section 141(k). The section provides that any “directors or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors.”
Nutrisystem, on the other hand, argues that Section 141(k) simply states that a majority of shareholders can remove directors and the statute doesn’t specify the percentage of shares that must be voted for the removal.
The litigation explores a question left open from another chancery court ruling—In re Vaalco Energy Shareholder Litigation. In a bench decision issued in December, Vice Chancellor J. Travis Laster invalidated a Vaalco Energy Inc. charter provision providing that board members could only be removed for cause. The judge held that directors of nonclassified boards may be removed without cause no matter what their charters or bylaws say. The judge also found that there are only two exceptions to shareholders’ authority to remove directors under Section 141(k)—a classified board or cumulative voting.
The Vaalco ruling sparked a rush by many companies to amend their bylaws.
If the chancery court finds Nutrisystem’s bylaw valid, that will boost Delaware corporations’ ability to circumscribe the right of shareholders to remove board members. Conversely, if the court agrees with the shareholder plaintiff, it will make clear that companies can’t impose a supermajority requirement on that right.
This isn’t the only open question from the Vaalco decision. The ruling focused on nonclassified boards, or boards in which directors are elected annually rather than at staggered periods. The decision didn’t address single-class boards. It remains to be seen whether a shareholder will test this issue.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)